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Abstract: Laugier-Hunziker syndrome (LHS) is a rare condition characterized by acquired hyperpigmen-
tation involving the lips, oral mucosa, acral surfaces, nails and perineum. While patients with LHS may
manifest pigmentation in all of the aforementioned areas, most present with pigmentation localized to
only a few of these anatomical sites. We herein report a patient exhibiting the characteristic pigment
distribution pattern associated with LHS. Since LHS is a diagnosis based on exclusion, we discuss the
differential diagnosis of mucocutaneous hyperpigmentation. Due to the benign nature of the disease, it
is critical to differentiate this disorder from conditions with similar mucocutaneous pigmentary changes
with somatic abnormalities that require medical management. We also explore potential mechanisms
that may explain the pathogenesis of LHS.
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Introduction
Laugier-Hunziker syndrome (LHS) is a benign pigmentary 
condition characterized by hyperpigmented mucocutaneous 
macules progressively arising during adulthood. The asymp-
tomatic melanotic macules most commonly involve the lips, 
oral mucosa, and acral surfaces, with occasional nail involve-
ment. While LHS is a rare disorder of unknown etiology, it 
is important to differentiate it from conditions with similar 
pigmentary changes with somatic abnormalities that neces-
sitate further investigation and treatment. In this case, we 
present the history, clinical findings, and histopathology of 
a patient exhibiting the pigmentary features consistent with 
LHS in order to highlight the critical differential diagnosis of 
asymptomatic mucosal and acral hyperpigmentation and to 
explore the potential pathogenesis of LHS.
Case Presentation
A man in his 50s presented with multiple pigmented macules 
of the lips, palate, and fingers. Over the course of one year, 
the patient noted the gradual onset and progression in the 
number of lesions and degree of pigmentation. The lesions 
were asymptomatic and the patient felt otherwise well. The 
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Laugier-Hunziker syndrome (LHS) is a rare condition characterized by acquired hyperpigmentation 
involving the lips, oral mucosa, acral surfaces, nails and perineum. While patients with LHS may mani-
fest pigmentation in all of the aforementioned areas, most present with pigmentation localized to only 
a few of these anatomical sites. We herein report a patient exhibiting the characteristic pigment distri-
bution pattern associated with LHS. Since LHS is a diagnosis based on exclusion, we discuss the dif-
ferential diagnosis of mucocutaneous hyperpigmentation. Due to the benign nature of the disease, it is 
critical to differentiate this disorder from conditions with similar mucocutaneous pigmentary changes 
with somatic abnormalities that require medical management. We also explore potential mechanisms 
that may explain the pathogenesis of LHS.
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Given the morphology and distribution of the pigmented 
macules on the palate, lower lip, and fingers, and based on 
the fact that the patient had no exposure to heavy metals, no 
signs of Addison’s disease, or Peutz-Jeghers syndrome, leads 
one to conclude that the patient has LHS.
patient’s history was significant for melanoma in situ which 
was treated five years prior to the onset of the pigmentation 
of his lips and fingers. The patient was a non-smoker and he 
had no other relevant medication history. The patient denied 
a history of trauma or exposures to heavy metals. There was 
no familial history of pigmentary disorders and digestive 
polyposis or tumors.
Physical examination revealed multiple 2 to 5 mm brown 
to grayish macules on the lower lip (Figure 1A) and two gray-
ish macules on the hard palate (Figure 2). On dermoscopy the 
macules on the lip revealed a fish scale-like dermoscopy pat-
tern (Figure 1B). There were several brown to grayish-brown 
macules on the lateral aspect of his right index, thumb, and 
middle fingers (Figure 3), accompanied by similar appearing 
macules on his left thumb. Dermoscopy revealed pigmented 
macules with a brown to grayish homogeneous pattern (Fig-
ure 4A, B). There were no pigmented lesions noted on the 
palms, soles, nails, perineum, or conjunctiva. No axillary or 
inguinal lymphadenopathy was found.
A biopsy of a representative lesion on the lower lip was 
performed. Histopathologic examination revealed hyperpig-
mentation of the stratum basalis. There was hyperparakera-
tosis and acanthosis of the epithelium, with elongated rete 
ridges, as well as a few melanophages in the dermis.
Figure 2. Clinical manifestations of the pigmented macules located 
on the hard palate. [Copyright: ©2017 Cusick et al.]
Figure 1. (A) Clinical manifestations of the pigmented macules of the lower lips, (B) dermoscopic examination of the pigmented lesions 
reveals a fish scale-like pattern. [Copyright: ©2017 Cusick et al.]
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Figure 3. Clinical manifestations of the pigmented macules of the 
lateral aspects of the second and third right finger. [Copyright: 
©2017 Cusick et al.
Figure 4. (A, B) Dermoscopic examination of the pigmented le-
sions reveal homogeneous brownish to grayish pattern. [Copyright: 
©2017 Cusick et al.]
A B
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cytic hyperplasia involved in formation of mucosal and acral 
macules of LHS. It has been shown that at the site of the 
ligand stem cell factor (SCF) injection (used for promoting 
hematopoiesis), there is an increased number of melanocytes, 
melanocytic dendrite extension and melanin [11]. With the 
xenografts of normal human skin, SCF stimulation resulted 
in hyperplasia of melanocytes, causing the increased size and 
number of melanocytes and expression of melanocyte differ-
entiation antigen, while inhibition of Kit resulted in decreased 
antigen expression, and size and number of melanocytes [11].
Several differential diagnoses must be considered in an 
adult patient presenting with multiple mucocutaneous pig-
mented macules. Due to the benign nature of the disease, it 
is critical to differentiate this disorder from conditions with 
similar mucocutaneous pigmentary changes with somatic 
abnormalities that require medical attention [12]. The dif-
ferential diagnosis considered for this adult patient with 
hyperpigmentation of fingers and lips included medication-
induced, exposures to heavy metals, Addison’s disease, and 
rare genetic syndromes such as Peutz-Jeghers syndrome (PJS).
Drug-induced pigmentation, most commonly associated 
with phenytoin, anti-malarial, and HIV medications, will usu-
ally occur after months or years of chronic use of drugs and 
resolves once the drug is discontinued [3]. Anti-malarial drug 
administration may cause asymptomatic hyperpigmented 
macules on the oral mucosa and pretibial shin [2]. Exogenous 
brown to black pigmentation may also result from exposure 
to tar, dirt, tobacco, and potassium permanganate [3]. For 
example, cigarette smoking may result in oral mucosal pig-
mentation in the anterior gingiva [13].
Addison’s disease, an endocrine disease caused by insuffi-
cient cortisol and aldosterone production, is characterized by 
hyperpigmentation of the skin and mucosal membranes, with 
increased level of circulating adrenocorticotropic hormone 
(ACTH). In Addison’s disease, longitudinal pigmented bands 
may appear on the nails and diffuse pigmentation may appear 
on mucosal surfaces, especially the buccal mucosa, gums, 
and tongue [3]. The well-circumscribed macules of LHS are 
distinctive from the more diffuse pigmentation of Addison’s 
disease. Negative systemic symptoms, such as fatigue and 
weight loss, and normal plasma levels of cortisol and ACTH 
rule out this possibility [14].
Peutz–Jeghers syndrome (PJS), an autosomal dominant 
genodermatosis due to mutations in the gene encoding serine/
threonine kinase 11 (STK11), is notable for mucocutaneous 
lentigines and intestinal polyposis [2]. Patients with PJS pres-
ent with hyperpigmented macules of oral and acral skin aris-
ing in the first few years of life. A histologic examination of 
these lesions shows increased melanin in the stratum basalis, 
and melanin is concentrated at the tips of the rete ridges [2]. 
Overlapping clinical features in both LHS and PJS may cause 
diagnostic confusion. In PJS, hyperpigmented macules of the 
Discussion
Laugier and Hunziker first reported an uncommon condition 
characterized by acquired melanotic hyperpigmented macules 
of the oral mucosa, lips, fingers, with occasional nail involve-
ment, in otherwise asymptomatic patients [1]. LHS typically 
arises during adulthood and follows a chronic course without 
remission. The lesions are most commonly located on the lips 
and oral cavity, including the buccal mucosa, soft palate, hard 
palate, and gingiva [2]. Longitudinal melanonychia is evident 
in about half the cases. Pigmentation may spread from the 
proximal nail fold into the surrounding skin [3].
Histopathologic features of the pigmented macules 
described by Laugier and Hunziker demonstrated intraepi-
dermal melanosis without melanocytosis [1]. The majority 
of subsequent reports of melanotic macules from LHS dem-
onstrate normal numbers and normal morphologic appear-
ance of melanocytes with increased basal pigmentation due 
to melanin deposition without hyperplasia of melanocytes 
[3]. However, there have been some publications reporting 
increased numbers of intraepidermal melanocytes distrib-
uted in a lentiginous pattern [4,5]. Due to the rarity of this 
condition, there are no long-term studies to determine risk 
for malignant degeneration. With that said, there is one 
reported case of mucosal melanoma of the upper lip in a 
patient affected by the long-standing melanocytic hyperplasia 
of LHS [6].
Although the etiology of LHS is unknown, the patho-
genesis is thought to be due to an alteration of melanocytes, 
resulting in an increased synthesis of melanosomes and their 
transport to the basal cell layers, resulting in the accumulation 
of melanin in the basal keratinocytes of the epidermis [4].
To our knowledge, no prior studies have examined the 
significance of the distribution of the lesions in LHS. Local-
ization of this condition primarily to mucosal and acral 
surfaces may provide a clue into the mechanism of action of 
this disease. Advancements in our understanding of mucosal 
and acral melanoma have revealed the type III tyrosine kinase 
receptor c-Kit (CD117) as a key player in the oncogenic 
alterations involved in some acral and mucosal melano-
mas [7]. This is supported by evidence of successful use of 
c-Kit inhibitors, such as imatinib, in achieving remission for 
patients with metastatic melanomas from acral and mucosal 
sites with c-Kit aberrations [8,9].
Gain-of-function mutations in the Kit oncogene, encod-
ing c-Kit, are associated with chronic myeloid leukemia and 
gastrointestinal stromal tumor (GIST) development [10]. 
Interestingly, there are reported cases of germline mutation of 
c-Kit demonstrated in a patient with numerous lentigines and 
GISTs [10]. It is possible that the gain-of-function mutation 
of c-Kit pathway may activate the downstream pathways and 
promote proliferation of melanocytes, leading to the melano-
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oral mucosa and acral skin may be present at birth or appear 
in early life, in contrast to the lesions in LHS, which usually 
occur in adulthood. Unlike LHS, lesions of PJS typically do 
not involve the tongue, palate, or fingernails. Lastly, PJS is 
associated with hamartomatous polyps of the gastrointestinal 
tract, whereas LHS is not [3].
Although rare, Bandler syndrome presents as hyperpig-
mented macules on the hands, nails, and oral mucosa and is 
associated with intestinal vascular malformation developing in 
infancy [3]. LAMB syndrome is characterized by pigmentation 
of the skin mucosa, atrial and mucocutaneous melanomas, 
and multiple blue nevi [2]. LEOPARD syndrome is manifested 
by numerous lentigines, electrocardiographic abnormalities, 
occasional hypertelorism, pulmonic stenosis, abnormalities of 
genitalia, retardation of growth, and deafness [2].
Given that our patient’s pigmented macules of the lips 
and oral mucosa appeared late in life, in the absence of other 
somatic abnormalities and without a relevant family history 
of findings typical of PJS, our diagnosis was most consistent 
with LHS. In conclusion, LHS is an important consideration 
with a patient presenting with otherwise asymptomatic muco-
sal and acral hyperpigmentation. Despite the low prevalence 
of the LHS, the prompt clinical recognition avoids the need 
for excessive and invasive procedures and workup.
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